A new approach to the medical management of glaucoma, from the bench to the clinic, and beyond: The proctor lecture

Investigative Ophthalmology and Visual Science

Volumn 42, Issue 6, 2001, Pages 1126-1133

  Bito, L Z ^a  

^a NONE   (Hungary)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; PROSTAGLANDIN DERIVATIVE; PROSTAGLANDIN E2; PROSTAGLANDIN F2 ALPHA;

AQUEOUS HUMOR FLOW; ARTICLE; CLINICAL RESEARCH; GLAUCOMA; HISTORY OF MEDICINE; HUMAN; HYPEREMIA; INTRAOCULAR PRESSURE; NONHUMAN; PRIORITY JOURNAL; RABBIT; TONOMETER;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; AQUEOUS HUMOR; AWARDS AND PRIZES; BLOOD-AQUEOUS BARRIER; CAPILLARY PERMEABILITY; CIRCADIAN RHYTHM; DRUG THERAPY, COMBINATION; FLORIDA; GLAUCOMA; HUMANS; INTRAOCULAR PRESSURE; OPHTHALMIC SOLUTIONS; OPHTHALMOLOGY; PROSTAGLANDINS; SOCIETIES, SCIENTIFIC;

EID: 0035032382     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Zur kenntis der pharmakoligischen wirkungen von nativsekreten und extrakten mannlicher accessorischer geschlechtsdrusen
2. Prostaglandins and thromboxanes
3. Prostaglandins: Old concepts and new perspectives
4. A physiologic approach to the development of new drugs for glaucoma
5. A physiological approach to glaucoma management: The use of local hormones and the pharmacokinetics of prostaglandin esters
6. Prostaglandins: A new approach to glaucoma management with a new, intriguing side effect
7. Physiological aspects of glaucoma and its management
8. From PGF2a-isopropyl-ester to latanoprost: A review of the development of Xalatan
9. Some differences in uveal reactions between cats and rabbits
10. A simple chemical procedure for distinguishing E from F prostaglandins, with application to tissue extracts
11. Smooth muscle stimulating lipids in sheep iris, identification of prostaglandin F2a, prostaglandins and related factors
12. Steady-state concentrations of potassium in the ocular fluids
13. Transport of prostaglandins across the blood-brain and blood-aqueous barriers and the physiological significance of these absorptive transport processes
14. Transport functions of the blood-retinal barrier system and the micro-environment of the retina
15. Prostaglandin and non-prostaglandin mediated breakdown of the blood-aqueous barrier
16. Release of prostaglandins in ocular inflammation
17. Inactivation of prostaglandin E1 by ocular tissues in vitro
18. Accumulation and apparent active transport of prostaglandins by some rabbit tissues in vitro
19. Absorptive transport of prostaglandins from intraocular fluids to blood: A review of recent findings
20. Inhibition of pulmonary prostaglandin metabolism by inhibitors of prostaglandin biotransport (probenecid and bromcresol green)
21. Inhibition of renal prostaglandin metabolism and excretion by probenecid, bromcresol green and indomethacin
22. Beta-blockers
23. Inhibition of uveal prostaglandin transport in experimental uveitis
24. The effects of experimental uveitis on anterior-uveal prostaglandin transport and aqueous humor composition
25. Inflammatory effects of endotoxin-like contaminants in commonly used protein preparations
26. Intraocular fluid dynamics, III: The site and mechanism of prostaglandin transfer across the blood intraocular fluid barriers
27. Reduction of intraocular pressure by prostaglandins applied topically to the rabbit eye
28. Increased intraocular pressure produced by prostaglandins E1 and E2 in the cat eye
29. The effects of prostaglandins on the intraocular pressure of the rabbit
30. Long-term maintenance of reduced intraocular pressure by daily or twice daily topical application of prostaglandins to cat or rhesus monkey eyes
31. The pathophysiological effects of nitrogen mustard on the rabbit eye, I: The biphasic intraocular pressure response and the role of prostaglandins
32. The pathophysiological effects of nitrogen mustard on the rabbit eye, II: The inhibition of the initial hypertensive phase by capsaicin and the apparent role of substance P
33. Paradoxical ocular hypertensive effect of pilocarpine on echothiophate iodide treated primate eyes
34. Intraocular inflammation produced by X-irradiation of the rabbit eye
35. Species variations in the pathophysiological responses of vertebrate eyes to the chemical irritant, nitrogen mustard
36. Recent observations concerning the effects of cholinergic drugs on outflow facility in monkeys
37. 2
38. Impermeability of rabbit erythrocytes to prostaglandins
39. The putative and demonstrated miotic effects of prostaglandins in mammals
40. Presbyopia: An animal model and experimental approaches for the study of the mechanism of accommodation and ocular ageing
41. Accommodation and presbyopia
42. Functional morphology of accommodation in the raccoon
43. Accommodation dynamics in aging rhesus monkeys
44. The color of the human eye: A review of morphologic correlates and of some conditions that affect iridial pigmentation
45. Prostaglandin-induced iris color darkening
46. Zur farbe und struktur der menschlichen iris, 1: Morphologische untersuchungen
47. Changes in eye colour during early childhood: Sex and genetic difference
48. Eye color changes past early childhood
49. The incidence and time-course of latanoprost-induced iridial pigmentation as a function of eye color
50. Decreasing stromal iris pigmentation as a risk factor for age-related macular degeneration
51. Oxidative stress-induced cataract: Mechanism of action
52. The pigmentary system: An expanded perspective
53. Melanins, melanogenesis and melanocytes: Looking at their functional significance from the chemist's viewpoint
54. Pigment cell research: What directions?
55. Regulation of growth and melanogenesis of uveal melanocytes
56. Presence and rapid decline of early morning intraocular pressure peaks in glaucoma patients
57. Glaucoma: A physiologic perspective with Darwinian overtones
58. Effects of timolol, epinephrine, and acetazolamide on aqueous flow during sleep
59. Impact of intraocular pressure on venous outflow from the globe: A hypothesis regarding IOP-dependent vascular damage in normal-tension and hypertensive glaucoma
60. Around-the-clock (circadian) intraocular pressure reduction with once-daily application of 0.005% latanoprost, by itself, or in combination with timolol
61. Circadian intraocular pressure management with latanoprost: Diurnal and nocturnal intraocular pressure reduction and increased uveoscleral outflow
62. Drug firms reap profits on tax-backed research